InCVAX

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameInCVAX
Drug Alias NameGCinCVAX-N-dihydro-galacto-chitosaninCVAX-GCinCVAX-IP001IP-001
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungRectal Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanySwitzerland +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunophotonics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunophotonics IncUniversity Of Louisville
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungRectal Neoplasms +[7] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A